Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
Lhasa and the ICH M7 Guideline - 2020 ICH M7 India RoadshowMarch 2020pdf fileDerek NexusSarah NexusVitic NexusSetariaMirabilis
GSK MI risk assessment process Camicinal at al - 2020 ICH M7 India RoadshowMarch 2020pdf fileDerek NexusSarah NexusVitic Nexus
Hazard Assessment of Potentially Mutagenic Impurities - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah Nexus
ICH M7 - Regulatory Updates and Industry Practices - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah Nexus
Lhasa Expert Review Developments - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah NexusVitic Nexus
Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy options - RecordingJanuary 2020Mirabilis
Quantitative Analysis of In Vivo Dose-Response Data for Risk Assessment and Regulatory Decision Making - RecordingJanuary 2020
Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy optionsJanuary 2020pdf fileMirabilis
Quantitative Analysis of In Vivo Dose-Response Data for Risk Assessment and Regulatory Decision Making - A Case Study of AlkylnitrosaminesJanuary 2020pdf file
Future Developments AOP Networks And Predicting Secondary PharmacologyJanuary 2020pdf fileEffirisKaptis
Carcinogenicity Adverse Outcome PathwaysJanuary 2020pdf fileDerek NexusKaptisVitic Nexus
Beyond Mutagenicity: Supporting Toxicity Assessments For Other EndpointsJanuary 2020pdf fileDerek Nexus
Setaria 3.1.1 Installation GuideJanuary 2020pdf fileSetaria
The use of in-silico tools to assist in the practical management of impurities under ICH M7.December 2019
Approaches to Skin Sensitisation PredictionNovember 2019pdf fileDerek Nexus
Data Sharing with LhasaNovember 2019pdf fileDerek Nexus
Improving performance of structural alerts for the in vitro mutagenicity endpoint using proprietary data - Rachael TennantNovember 2019pdf fileDerek Nexus
Using an Adverse Outcome Pathway framework to ground approaches in predictive toxicologyNovember 2019pdf file
Undertaking expert review under the ICH M7 guidelines - Chris BarberNovember 2019pdf file
Use of Mirabilis based purge calculations to understand MI related risk and control strategy options - Chris BarberNovember 2019pdf fileMirabilis
Mirabilis - Case Study of a Risk Assessment for ICH M7 Control of ImpuritiesNovember 2019pdf fileMirabilis
Achieving Innovation Through Collaborative ProgressNovember 2019pdf fileDerek NexusVitic NexusIntermediates
Generation of TD50 values for carcinogenicity study dataNovember 2019
2019 Webinar Zeneth 8: A faster, more intuitive, degradation predictive system - RecordingNovember 2019Zeneth
2019 Webinar Zeneth 8: A faster, more intuitive, degradation predictive system - SlidesNovember 2019pdf fileZeneth

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.